Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genelux (GNLX) Cash & Equivalents (2022 - 2025)

Genelux (GNLX) has 3 years of Cash & Equivalents data on record, last reported at $34.5 million in Q3 2024.

  • For Q3 2024, Cash & Equivalents rose 15.39% year-over-year to $34.5 million; the TTM value through Sep 2024 reached $34.5 million, up 15.39%, while the annual FY2023 figure was $21.7 million, 5365.24% up from the prior year.
  • Cash & Equivalents reached $34.5 million in Q3 2024 per GNLX's latest filing, down from $40.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $40.4 million in Q2 2024 and bottomed at $397000.0 in Q4 2022.
  • Average Cash & Equivalents over 3 years is $24.2 million, with a median of $25.8 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: soared 5365.24% in 2023, then increased 15.39% in 2024.
  • A 3-year view of Cash & Equivalents shows it stood at $397000.0 in 2022, then skyrocketed by 5365.24% to $21.7 million in 2023, then surged by 58.85% to $34.5 million in 2024.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $34.5 million in Q3 2024, $40.4 million in Q2 2024, and $18.6 million in Q1 2024.